Illumina's attempt to prevent the ... companies must wait for our approval before a transaction can go ahead". Under EU law, the Commission can impose fines up to 10% of aggregate turnover on ...

The EU has blocked the merger of Illumina and Grail, saying the deal would stifle innovation in blood-based diagnostics for cancer diagnostics, just days after a bid by the US authorities to do ...